NCT07288216Phase 2Recruiting

Transition to KPL-387 Monotherapy Dosing & Administration Study

Study sponsor: Kiniksa Pharmaceuticals International, plc · KNSA

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2027-12-31Estimated

Enrollment · participants80Estimated

Source updated2026-08-11Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2026-01-20 · 1 field changed

Recruitment status changed

− Before

~~Not yet recruiting~~

+ After

Recruiting

Check registry source